Mainstream

Omeros signals debt reduction of over $100M and prioritizes narsoplimab launch following FDA BLA acceptance

Omeros signals debt reduction of over $100M and prioritizes narsoplimab launch following FDA BLA acceptance

Post ContentomerRead More

You might also be interested in reading XRP’s Silent Build-Up: A ‘Detonation’ May Be Next, Analyst Says.

May 16, 2025
In Mainstream